HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,177-7,188 of 27,277
Drug study icon
CompletedEUCTR 2006-001471-37

A Randomized, Double-Blind Comparison of Atomoxetine versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
ADHDHistorical research record
Countries
Germany
Sponsor
Lilly Deutschland GmbH, Teichweg 3, 35396 Gießen
Drug study icon
CompletedNCT00190775

Atomoxetine compared with placebo for adult ADHD over 38 weeks

About this title

A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Read the official source — NCT00190775
What is this study about?

Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Irvine
ADHDMedication studyAges 18+
Countries
United States
Sponsor
Eli Lilly and Company
Drug study icon
CompletedEUCTR 2006-000846-38

A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Extended-Release Paliperidone as Maintenance Treatment After an ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
BipolarityHistorical research record
Countries
Germany
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedEUCTR 2005-005812-25

A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexi...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Greece
BipolarityHistorical research record
Countries
Greece, Lithuania
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedEUCTR 2014-004586-24

A Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium, Czechia, Germany, + 5 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2014-004588-19

A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Subjects with Tre...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
United Kingdom, Belgium, Bulgaria, + 5 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2022-000461-41

A Randomized, Double-blind, Multicenter, Parallel-Group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
DepressionHistorical research record
Countries
France, Bulgaria, Czechia, + 1 other
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2011-001436-33

A randomized, double-blind, parallel-group study of the safety and efficacy of RO4917523 versus placebo, as adjunctive therapy in patients with major depressive disorder with inadequate response to...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
DepressionHistorical research record
Countries
Germany
Sponsor
F. Hoffmann-La Roche Ltd

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.